Abstract
Circulating blood cell counts, serum cortisol, proteins, alkaline phosphatase, carcinoembryonic antigen and CA15.3 displayed significant circadian rhythms in a group of 13 women with metastatic breast cancer. Statistical significance (P<0.05) was assessed with both analysis of variance and cosinor analysis. All patients had been previously treated with chemo-and/or radiotherapy and/or antiestrogens. All patients had been treatment-free for 1 month prior to the study. Each patient had blood drawn every 4 h for 48 h. Circadian rhythms were examined as a function of performance status, graded according to the World Health Organization, liver involvement and number of metastatic sites. Group circadian rhythms in serum cortisol or proteins were abolished in patients with liver metastases, and were altered in cases of poor performance status. Circulating leukocytes, neutrophils or platelets did not exhibit synchronized circadian rhythmicity in patients with poor performance status or liver metastases. The number of metastatic organs had a minor influence on circadian rhythmicity. These results suggest that rhythm alteration may be associated with both poor performance status and liver metastases in patients with advanced breast cancer. Such alteration of the normal circadian time structure may favor and/or result from cancer spread.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CEA :
-
Carcinoembryonic antigen
References
Bailleul F, Lévi F, Reinberg A, Mathé G (1986) Interindividual differences in the circadian hematologic time structure of cancer patients. Chronobiol Int 3:47–54
Bargiello T, Jackson FR, Young M (1984) Restoration of a circadian behavioural rhythms by gene transfer inDrosophila. Nature 312:752–754
Benavides M (1991) Cancer avancé de l'ovaire: approche chronobiologique comme nouvelle stratégie du traitement et de la surveillance clinique et biologique. Thèse de Doctorat ès-Sciences, Université Paris XI
De Prins J, Cornelissen G, Malbecq W (1986), Statistical procedures in chronobiology and chronopharmacology. Annu Rev Chrono-pharmacol 2:27–141
Dunlap JC (1990) Closely watched clocks: molecular analysis of circadian rhythms inNeurospora andDrosophila. Trends Genet 6:159–165
Falkson G, Gelman R, Falkson C, Glick J, Harris J (1991) Factors predicting for response, time to treatment failure and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group Study. J Clin Oncol 9:2153–2161
Focan C (1983) Le rythme nycthéméral de la prolifération tumorale. Aspects expérimentaux et cliniques. Implications pour la chimiothérapie oncolytique. Thèse de Doctorat ès-Sciences Biomédicales Expérimentales, Université de Liège
Focan C, Focan-Henrard D, Frère MH, Le Hung S, Castronovo V, Collette J, Franchimont P, Touitou Y, Lévi F, Roemeling RW von, Hrushesky WJ (1986a) Circadian CEA variability: when to sample? J Clin Oncol 4:607–608
Focan C, Focan-Henrard D, Colette J, Mechkouri M, Lévi F, Hrushesky WJ, Touitou Y, Franchimont P (1986b) Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alphafetopretein (AFP) in humans. Anticancer Res 6:1137–1144
Gautherie M, Gros C (1977) Circadian rhythm alteration of skin temperature in breast cancer. Chronobiologia 4:1–17
Haus E, Touitou Y (1994) Chronobiology in laboratory medicine. In: Touitou Y, Haus E (eds.) Biologic rhythms in clinical and laboratory medicine, Springer, Paris Berlin Heidelberg New York, pp 673–708
Haus E, Lakatua D, Swoyer J, Sackett-Lundeen L (1983) Chronobiology in hematology and immunology. Am J Anat 168:467–517
Klein DC, Moore RY, Reppert SM (1983) Suprachiasmatic nucleus. The mind's clock. Oxford University Press, New York
Klevecz R, Shymko R, Braly P (1987) Circadian gating of S phase in human ovarian cancer. Cancer Res 47:6267–6271
Konopka RJ, Benzer S (1971) Clock mutants ofDrosophila melanogaster. Proc Natl Acad Sci USA 68:2112–2116
Lévi F, Canon C, Blum JP, Mechkouri M, Reinberg A, Mathé G (1985) Circadian and/or circahemidian rhythms in nine lymphocyte-related variables from peripheral blood of healthy subjects. J Immunol 134:217–222
Mick R, Begg CB, Antman KH, Korzun AH, Frei E (1989) Diverse prognosis in metastatic breast cancer. Who should be offered alternative initial therapies? Breast Cancer Res Treat 13:33–38
Nash CH III, Jones SE, Moon TE, Davis SL, Salmon SE (1980) Prediction of outcomes in metastatic breast cancer treated with doxorubicin combination chemotherapy. Cancer 46:2380–2388
Nelson W, Tong Y, Lee JK, Halberg F (1979) Methods for cosinor rhythmometry, Chronobiologia 6:305–323
Reinberg A, Smolensky M (1983) Biological rhythms and medicine. Cellular, metabolic, physiopathologic and pharmacologic aspects, Springer, New York
Reinberg A, Lagoguey M, Cesselin F, Touitou Y, Legrand JC, Delasalle A, Antréassian J, Lagoguey A (1978) Circadian and circannual rhythms in plasma hormones and other variables of five healthy young human males. Acta Endocrinol 88:417–485
Reinberg A, Touitou Y, Restoin A, Migraine C, Lévi F, Montagner H (1985) The genetic background of circadian and ultradian rhythm patterns of 17-hydroxycorticosteroids: a cross-twin study J Endocrinol 105:247–253
Touitou Y, Haus E (1994) Biologic rhythms in clinical and laboratory medicine. Springer, New York Berlin Heidelberg
Touitou Y, Sulon J, Bogdan A, Touitou C, Reinberg A, Beck H, Sodoyez JC, Van Cauwenberge H (1982) Adrenal circadian system in young and elderly human subjects: a comparative study. J Endocrinol 93:201–210
Touitou Y, Sulon J, Bogdan A, Reinberg A, Sodoyez JC, Demey-Ponsart E (1983) Adrenocortical hormones, ageing and mental condition: seasonal and circadian rhythms of plasma 18-hy-droxy-11-deoxycorticosterone, total and free cortisol and urinary corticosteroids. J Endocrinol 96:53–64
Touitou Y, Touitou C, Bogdan A, Reinberg A, Auzéby A, Beck H, Guillet P (1986) Differences between young and elderly subjects in seasonal and circadian variations of total plasma proteins and blood volume as reflected by hemoglobin, hematocrit and erythrocyte counts. Clin Chem 32:801–804
Touitou Y, Sothern RB, Lévi F, Focan C, Bogdan A, Auzéby A, Franchimont P, Roemeling RW von, Hrushesky WJ (1988) Sources of predictable tumor marker variation within the so called normal range: circadian and circannual aspects of plasma carcinoembryonic antigen (CEA) in health and disease. J Tumor Marker Oncol 3:351–359
Touitou Y, Bailleul F, Lévi F, Bogdan A, Touitou C, Metzger G, Mechkouri M (1990) Circadian rhythms of tumor markers in breast cancer patients. Prog Clin Biol Res 341:59–66
Van Coevorden A, Mockel J, Laurent E, Kerkhofs M, L'Hermite-Balériaux M, Decoster C, Nève P, Van Cauter E (1991) Neuroendocrine rhythms and sleep in aging men. Am J Physiol 260:E651-E661
Voutilainen A (1953) Über die 24 Stunden Rhythmik der Mitofrequenz in malignen Tumoren. Acta Pathol Microb Scand Suppl 99:1–104
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Touitou, Y., Lévi, F., Bogdan, A. et al. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J Cancer Res Clin Oncol 121, 181–188 (1995). https://doi.org/10.1007/BF01198101
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01198101